Award
NIH Reporter #3OT2CA278686-01S2
NexTGen - STANFORD
Recipient
Stanford University
Awarded
August 14, 2026
Identifier
3OT2CA278686-01S2
Award for developing next-generation T cell therapies for childhood cancers, including studies on tumor targets and microenvironment, aiming for clinical translation.
Description
The project focuses on developing next-generation T cell therapies for childhood cancers, with detailed studies on tumor targets and tumor microenvironment, and aims to translate these into clinical applications.